STAT1 and colitis: While an amelioration of experimental colitis was reported in an initial assessment with STAT1 knockout mice [45] and upon specific pharmacologic inhibition of STAT1 in T cells [46], it has also been shown that reduced IL-19-dependent STAT1 signaling in macrophages results in enhanced production of pro-inflammatory cytokines [47].